News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...


Recent Postings


Archive


Tags

Dendreon (DNDN) JUNO (JUNO) Aimmune Therapeutics (AIMT) Micromet (MITI) Agenus (AGEN) ImmunoGen (IMGN) NANTKWEST (NK) Regeneron (REGN) GUARDIAN HEALTH Revlimid (lenolidamide) Global Cell Therapeutics (GBT) Exelixis (EXEL) Sanofi-Aventis (SAN) Gilead (GILD) Sequenom (SQNM) Intrexon (XON) Benlysta (belimumab) Biocryst (BCRX) Xoma (XOMA) Mirati Therapeutics (MRTX) Intermune (ITMN) IDERA (IDRA) CRISPR Therapeutics (CRSP) Sangamo (SGMO) Alder Biopharmaceuticals (ALDR) Ridaforolimus Illumina (ILMN) Sarepta (SRPT) Auspex (ASPX) NEKTAR (NKTR)) Rapamune AGOS (ARGS) Advaxis (ADXS) Genentech ADVENTRIX (ANX) Theravance Bio Pharma (TBPH) AstraZeneca (AZN) Alnylam (ALNY) ARCA (ABIO) Intercept (ICPT) MODERNA GlaxoSmithKline (GSK) Sanofi (SNA) Array Pharmaceuticals (ARRY) C4 Therapeutics NOVOCURE (NVCR) VANDA (VNDA) ZALTRAP™ Anadys (ANDS) TOKAI (TKAOI) CompuGen (CGEN) Galena (GALE) Elan (ELN) Human Genome Sciences (HGSI) Merck (MRK) Endometrial Cancer Jazz Pharmaceuticals (JAZZ) Ariad (ARIA) Cytokinetics (CYTK) Velcade (bortezomib) HALOZYME (HALO) AERIE PHARMACEUTICALS Prosensa (RNA) Editas (EDIT) Sanofi (SNY) Bellicum (BLCM) Zerenex Onyx (ONXX) Dynavax (DVAX) SYNTA (SNTA) galapagos (GLPG) Adaptimmune (ADAP) Anacor (ANAC) Multiple Myeloma Roche (RHHBY) Ionis (IONS) Amgen (AMGN) Ziofpharm (ZIOP) Pluristem (PSTI) ABBVIE (ABBV) KERYX (KERX) INNOVIVA (INVA) Valeant Pharmaceuticals International (VRX) ARGOS (ARGS) Vertex (VRTX) Abbott Laboratories (ABT) Herceptin KITE (KITE) Trastuzumab-DM1 REGULUS (RGLS) Seattle Genetics (SGEN) Spike Therapeutics (ONCE) Incyte (INCY) SUNESIS PHARMACEUTICALS (SNSS) PTC Therapeutics (PTCT) Inovio (INO) Human Longevity (HLI) Tysabri Biogen Idec (BIIB) Theravance (THRX) RenenxBio (RGNX) Vitae Pharmaceuticals (VTAE) SERES THERAPEUTICS (MCRB) Bristol-Myers Squibb (BMY) OSI (OSIP) Prolor Biotech (PBTH) Telaprevir ISIS (ISIS) Agenus (AGEN Idenix (IDIX) ACADIA (ACAD) Roche (ROCHE) BIOMARIN (BMRN)